Molecular epidemiology of Mycobacterium tuberculosis in Lisbon;Epidemiologia molecular de Mycobacterium tuberculosis em Lisboa

Revista Portuguesa de Pneumologia

Volumn 14, Issue 2, 2008, Pages 239-259

  Portugal, Isabel ^a   Barreiro, Luís ^b   Vultos, Tiago ^b   Macedo, Rita ^c   Furtado, Cristina ^a   Antunes, António Fonseca ^c   Brum, Laura ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^c NONE

Author keywords

Molecular epidemiology; Multidrug resistance; Mycobacterium tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; RNA; STREPTOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE CLUSTER; GENE INSERTION; GENE PROBE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PORTUGAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; RNA FINGERPRINTING;

EID: 42349110801     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30233-6     Document Type: Article

References (25)

1. Direcção Geral de Saúde. Programa Nacional de Luta Contra a Tuberculose. Ponto da situação epidemiológica e de desempenho. 2003.
2. van Embden JD, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-9.
3. van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J Intern Med 2001;249:1-26.
4. Yang ZH, Bates JH, Eisenach KD, Cave MD. Secondary typing of Mycobacterium tuberculosis isolates with matching IS6110 fingerprints from different geographic regions of the United States. J Clin Microbiol 2001;39:1691-5.
5. Kremer K, van Soolingen D, Frothingham R, et al. Comparison of methods based on different molecular epidemiological markers for typing Mycobacterium tuberculosis complex strains: inter-laboratory study of discriminatory power and reproducibility. J Clin Microbiol 1999;37:2607-18.
6. Kamerbeek J, Schouls L, Kolk A, et al. Rapid detection and simultaneous strain difterentiation of Mycobacterium tuberculosis for diagnosis and tuberculosis control. J Clin Microbiol 1997;35:907-14.
7. Portugal I, Covas MJ, Brum L, et al. Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis. Int J Tub Lung Dis 1999;3:207-13.
8. David H, Levy-Frébault V, Thorel MF. Méthodes de laboratoire pour mycobactériologie clinique. 1989 Institut Pasteur, Paris.
9. Hermans P W, Messadi F, Guebrexabher H, et al. Usefulness of DNA typing for global tuberculosis epidemiology J Inf Dis 1995;171:1504-13.
10. Murray M, Alland D. Methodological problems in the molecular epidemiology of tuberculosis. Am J Epidemiol 2000;155: 565-71.
11. van Soolingen D, Borgdorff MW, de Haas PEW, et al. Molecular epidemiology in the Netherlands: a nation-wide study from 1993 trough 1997. J Inf Dis 1999; 180: 726-736.
12. Murray M, Nardell E. Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge. Bull World Health Organ 2002;80:477-82.
13. Bauer J, Yang Z, Poulsen S, Andersen AB. Results from 5 y of nation-wide DNA fingerprint of Mycobacterium tuberculosis complex isolates in a country with a low incidence of Mycobacterium tuberculosis infection. J Clin Microbiol 1998;36:305-8.
14. van Soolingen D, Hermans P W, de Haas PEW, Soll D R, van Embden J D A. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 1991;29:2578-86.
15. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco. N Engl J Med 1994;330:1703-9.
16. Direcção Geral de Saúde. Programa Nacional de Luta Contra a Tuberculose. Ponto da situação epidemiológica e de desempenho. 2002.
17. Yeh RW, Ponce de León A, Agasino CB, et al. Stability of Mycobacterium tuberculosis DNA genotypes. J Infect Dis 1998;177:1170-1111.
18. Glynn J R, Whiteley J, Bifani P J, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002;8:843-9.
19. Lillebaek T, Dirksen A, Kok-Jensen A, Andersen A.B. A dominant Mycobacterium tuberculosis strain emerging in Denmark. Int J Tuberc Lung Dis 2004;8:1001-6.
20. Victor T C, de Haas P, Jordaan A, et al. Warren R. Molecular characteristics and global spread of Mycobacterium tuberculosis with a Western Cape F11 genotype. J Clin Microbiol 2004;42:769-72.
21. Blackwood K, Al-Azem A, Elliott L, Hershfield E, Kabani A. Conventional and molecular epidemiology of tuberculosis in Manitoba. BMC Infect Dis 2003;3:1-11.
22. Hermans P W, Messadi F, Guebrexabher H, et al. Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect Dis 1995;171:1504-13.
23. Chevrel-Dellagi D, Abderrahman A, Haltiti R, Koubaji H, Gicquel B, Dellagi K. Large-scale DNA finger-printing of Mycobacterium tuberculosis strains as a tool for epidemiological studies of tuberculosis. J Clin Microbiol 1993;31:2446-50.
24. World Health Organization. Anti-tuberculosis drug resistance in the World. Report No.2: Prevalence and trends. 2000. WHO/CDS/TB/2000.278. Geneva:WHO,2000.
25. World Health Organization. Anti-tuberculosis drug resistance in the World. Report No.3. 2004. WHO/, Geneva: WHO, 2004.